Abstract:Abstract BAG-1 (bcl-2-associated athanogene-1) is a multifunctional protein which can interact with a number of molecules to regulate diverse biological processes including apoptosis, proliferation, signal transduction and transcription. BAG-1 protects cells from a wide range of apoptotic stimuli including radiation, hypoxia and chemotherapeutic agents and growth factor withdrawal. Therefore, BAG-1 may contribute to reduced cell death in cancer development, as well as to resistance to important therapeutic agents. Our study showed that the TAM sensitive cell line MCF-7 expressed lower levels of BAG-1 than the TAM resistant cell line MCF-7/TAMR, which was induced from MCF-7 cell line by culturing in medium containing 4-OH TAM (1×10-7M) for 6 months. Our study also found that down-regulation of BAG-1 significantly enhanced the sensitivity of the TAMR/MCF-7 cells to TAM treatment. Additionally, we used vectors carrying the individual BAG-1 isoforms to transfect the MCF-7 cells, and found that BAG-1 p50 was the only isoform that inhibited the TAM-induced apoptosis in the MCF-7 cells, while the other isoforms had little effect. Besides, we detected strong expression of BAG-1 in several breast cancer cell lines including T47D, MCF-7, MDA-MB231 and SK-BR-3. We even observed a 1.56 fold increase of EGFR in T47D cells transfected with BAG-1 siRNA when compared with the negative control. To further explore the association between BAG-1 expression and Gefitinb response in breast cancer cell lines, we used Gefitinb of different concentrations to treat cells for 24 hours, 48 hours and 72 hours respectively. The results of cell viability assay indicated that the down-regulation of BAG-1 in breast cancer cell line T47D significantly enhanced the T47D cells' sensitivity to Gefitinb-induced apoptosis. In summary, our results indicated that BAG-1 may have influence in the development of TAM resistance and Gefitinb resistance in breast cancer. However, our study was conducted in breast cancer cells in vitro; further studies on the relationship between BAG-1 expression and response to TAM and Gefitinb in a large cohort of breast cancer patients may be needed to confirm our findings. Citation Information: Cancer Res 2012;72(24 Suppl):Abstract nr P6-04-28.

Interaction of BAG-1 with Retinoic Acid Receptor and Its Inhibition of Retinoic Acid-induced Apoptosis in Cancer Cells

Molecular Recognition of CYP26A1 Binding Pockets and Structure–activity Relationship Studies for Design of Potent and Selective Retinoic Acid Metabolism Blocking Agents

Receptor Unique Anti-Activator Protein-1 Activity of Retinoic Acid Updated Version

Anticancer Effect of Retinoic Acid Via AP-1 Activity Repression is Mediated by Retinoic Acid Receptor Α and Β in Gastric Cancer Cells

Abstract P6-04-28: Changes in BAG-1 Expression Level Affect the Tamoxifen-induced Apoptosis and Gegitinb-induced Apoptosis in Breast Cancer Cells

Gene Silencing of BAG-1 Modulates Apoptotic Genes and Sensitizes Lung Cancer Cell Lines to Cisplatin-Induced Apoptosis

Retinoic Acid Receptor Beta is Required for Anti-Activator Protein-1 Activity by Retinoic Acid in Gastric Cancer Cells.

Bag-1 stimulates Bad phosphorylation through activation of Akt and Raf kinases to mediate cell survival in breast cancer

Identification of Retinoic Acid As an Inhibitor of Transcription Factor Nrf2 Through Activation of Retinoic Acid Receptor Alpha

Downregulation of BAG‑1 in T47D Cells Promotes Resistance to Tamoxifen Via Activation of the PI3K/Akt/mTOR Signaling Pathway.

BAG3: a New Therapeutic Target of Human Cancers?

Loss of CAK phosphorylation of RAR{alpha} mediates transcriptional control of retinoid-induced cancer cell differentiation.

Inhibition of trans-retinoic acid-resistant human breast cancer cell growth by retinoid X receptor-selective retinoids.

The effect pathway of retinoic acid through regulation of retinoic acid receptor α α α α α in gastric cancer cells

Molecular Chaperones and Cochaperones As Regulators of the Transcriptional Activity of the Glucocorticoid Receptor

[Mechanism of Retinoic Acid Receptor Alpha-Mediated Growth Inhibition of Gastric Cancer Cells by All-Trans Retinoic Acid].

Retinoic Acid Nuclear Receptor Α (rarα), a Major Role in Mediating Retinoids Inhibition of Growth in Human Breast Carcinoma Cells

Bcl2-associated Athanogene 3 Interactome Analysis Reveals a New Role in Modulating Proteasome Activity

MIR34Aregulates Autophagy and Apoptosis by Targetinghmgb1in the Retinoblastoma Cell

[Molecular Mechanism of the Inhibitory Effect of Retinoic Acid-Induced Gene G Protein on Tumor Cell Proliferation].

Bcl-2-associated athanogene 3(BAG3) is associated with tumor cell proliferation, migration, invasion and chemoresistance in colorectal cancer